Skip to main content
. Author manuscript; available in PMC: 2020 Sep 7.
Published in final edited form as: Endocr Relat Cancer. 2018 Jun 12;25(10):853–864. doi: 10.1530/ERC-18-0150

Figure 1.

Figure 1.

Roniciclib induces cytotoxicity in well-differentiated thyroid cancer cells. Cytotoxicity was evaluated in cells treated with a series of six two-fold dilutions of roniciclib starting from 100 nmol/L. Dose-response curves were obtained on day 4 using LDH assays. The median-effect dose (IC50) of roniciclib on day 4 was calculated for each cell line using CompuSyn software.